国家肺癌筛查试验的手术结果是否反映现代胸外科实践?
该研究分析国家肺癌筛查试验(NLST)中因确诊肺癌行手术切除患者的术式与术后并发症,共评估手术患者并发症、30天死亡率及独立危险因素。结果显示总体并发症率31%、主要并发症15.5%、30天死亡率1.7%,亚肺叶切除与胸腔镜入路与并发症/死亡减少相关或接近相关。
要点
- NLST手术切除患者30天死亡率为1.7%,主要并发症率15.5%,总体并发症率31%。
- 仅29.6%患者接受胸腔镜切除,80%行肺叶切除,16.1%行亚肺叶切除。
- multivariable分析中亚肺叶切除(OR 0.59;95%CI 0.38-0.94)与并发症/死亡减少显著相关。
核心结论
- 筛查发现的肺癌患者手术切除后手术死亡率和术后并发症率均很低。
- 增加亚肺叶切除和微创手术方式的使用可能与更少并发症相关。
研究设计与样本
- 基于NLST数据库的回顾性分析,纳入因确诊肺癌行手术切除的患者,重点评估术后并发症。
- 数值变量用Mann-Whitney U检验,分类变量用χ2检验,并对术后并发症独立危险因素行单因素和多因素logistic回归分析。
主要发现
- 手术患者中80%(n=821)行肺叶切除,4.1%(n=42)行全肺切除,16.1%(n=166)行亚肺叶切除,其中69%(n=114)为楔形切除。
- 仅29.6%(n=305)的患者接受胸腔镜切除。
- 总体并发症率31%(n=318),主要并发症率15.5%(n=160),最常见为持续漏气(n=67,6.5%)。
- 呼吸衰竭(n=28,2.7%)、持续通气(n=9,0.9%)、心肌梗死或心脏骤停(n=7,0.7%)、卒中(n=2,0.2%)均少见。
- 切除患者总体30天死亡率为1.7%(n=18)。
关键数值与推荐
- 多因素分析中,吸烟包年史较高(OR 1.01;95%CI 1.001-1.01)和肺部合并症(OR 1.34;95%CI 0.98-1.82)与并发症/死亡相关显著或接近显著。
- 亚肺叶切除(OR 0.59;95%CI 0.38-0.94)和电视辅助胸腔镜手术入路(OR 0.76;95%CI 0.56-1.04)与并发症/死亡减少相关显著或接近显著。
临床怎么用
- 解读NLST手术结果时需注意其胸腔镜比例低、肺叶切除为主的年代特征,不能直接等同于现代胸外科实践。
- 对筛查发现的肺癌患者,亚肺叶切除和微创入路可能有助于减少并发症,但需结合患者选择与分期。
- 术前应关注吸烟包年史和肺部合并症,以识别并发症/死亡风险较高的患者。
局限性
- 原文摘要未报告具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Surgical data from the National Lung Screening Trial (NLST) has yet to be closely examined. We sought to analyze surgical procedures and complications from the NLST to determine their relevance to modern surgical practice. METHODS: The NLST database was queried for patients who underwent surgical resection for confirmed lung cancer, specifically evaluating postoperative complications. Numerical variables were compared using the Mann-Whitney U test. Categorical variables were compared using the χ2 test. Logistic regression uni- and multivariable analysis of independent risk factors of postoperative complications was performed. RESULTS: At operation, 80% of patients (n = 821) had lobectomy, 4.1% (n = 42) had pneumonectomy, and 16.1% (n = 166) had sublobar resection, among whom 69% (n = 114) had wedge resection. Only 29.6% (n = 305) of the cohort had a thoracoscopic resection. Although the overall rate of surgical patients with any complication was 31% (n = 318), only 15.5% of patients (n = 160) had major complications, most commonly prolonged air leaks (n = 67, 6.5%). Respiratory failure (n = 28, 2.7%), prolonged ventilation (n = 9, 0.9%), myocardial infarction or cardiac arrest (n = 7, 0.7%), and stroke (n = 2, 0.2%) were rare events. Overall 30-day mortality in patients undergoing resection was 1.7% (n = 18). On multivariable analysis, greater smoking pack history (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.001-1.01) and pulmonary comorbidities (OR, 1.34; 95% CI, 0.98-1.82) were significant or approached significance for an association with complications/death, whereas sublobar resection (OR, 0.59; 95% CI, 0.38-0.94) and video-assisted thoracoscopic surgery approach (OR, 0.76; 95% CI, 0.56-1.04) were significant or approached significance for an association with decreased rates of complications/death. CONCLUSIONS: Operative mortality and postoperative morbidity were very low in patients undergoing resection for screen-detected lung cancer. Increased use of sublobar resection and minimally invasive surgical approaches may be associated with fewer complications.
引用
- Kamel MK, Lee B, Harrison S, et al. Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice? J Thorac Cardiovasc Surg. 2018. PMID: 31288364. doi:10.1016/j.jtcvs.2018.11.139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。